Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

PTC Therapeutics (PTCT) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$71.81

up-down-arrow $-0.88 (-1.21%)

As on 27-Aug-2026 16:18EDT

Market cap

info icon

$5,827 Mln

Revenue (TTM)

info icon

$1,009 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1743.3

Div. Yield

info icon

0 %

Edit peer-selector-edit
PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)
 5,827 16,614 17,326 13,400 12,305
Revenue ($ Mln)
 1,009 1,054 2,782 2,436 670
Net Profit ($ Mln)
 -38.38 755.85 491.50 860.62 -319.95
Net Margin (%)
 -3.80 71.69 17.67 35.33 -47.79
RoE (%)
 -- -- 110.09 42.98 -71.14
Price to Earnings
 -- 19.38 36.49 17.01 --
Price-To-Book
 1,743.27 10.05 39.43 7.27 26.44

Income Statement ($ Mln)

PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Operating Revenue arrow
1,008.75 1,054.37 2,782.29 2,435.92 669.50
Cost of Revenue arrow
180.19 103.47 1,982.07 85.67 19.14
Gross Profit arrow
1,658.90 588.53 760.62 2,236.43 829.45
Operating Expenses arrow
712.31 841.45 216.81 1,378.74 895.93
Operating Profit (EBIT) arrow
116.26 109.45 583.40 971.51 -226.44
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-67.07 101.11 598.92 1,035.47 -252.08
Provision for Tax arrow
-28.69 -654.74 107.42 174.84 20.05
Profit after Tax (Net Income) arrow
-38.38 755.85 491.50 860.62 -319.95
Minority Interest arrow
0.00 0.00 0.00 0.00 -47.83
Consolidated Profit arrow
0.00 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds arrow
-165.36 1,435.90 433.86 1,843.76 465.53
Minority Interest arrow
0.00 0.00 0.00 0.00 -47.83
Non-Current Liabilities arrow
2,644.77 384.48 187.89 288.55 1,362.63
Current Liabilities arrow
771.07 464.70 1,435.43 361.93 283.35
Total Liabilities arrow
2,898.77 1,302.02 1,975.47 2,844.42 1,385.30

Assets ($ Mln)

PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets arrow
633.12 895.24 1,006.90 1,243.41 440.60
Current Assets arrow
2,617.36 1,389.84 1,050.29 1,250.82 1,671.41
Total Assets arrow
2,898.77 1,302.02 1,975.47 2,844.42 1,385.30
Total Debt* arrow
696.47 449.89 120.10 165.93 864.07
Net Current Assets arrow
1,846.29 0.00 -385.14 888.90 1,388.07

Cashflow ($ Mln)

PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities arrow
711.20 51.77 713.22 884.27 179.55
Cash Flow from Investing Activities arrow
-861.98 -8.15 -31.14 350.44 -129.29
Cash from Financing Activities arrow
331.09 34.89 -860.39 -969.59 74.01
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
ROCE (%) arrow
35.24 -30.01 53.56 32.82 -0.17
ROE (%) arrow
-104.75 163.18 110.09 42.98 -71.14
ROA (%) arrow
-1.05 26.53 15.64 29.32 -16.12
EBIT Margin (%) arrow
11.72 5.73 21.13 31.04 -0.77
Net Margin (%) arrow
-3.80 71.69 17.67 35.33 -47.79
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%) arrow
-42.84 114.85 24.67 9.23 12.22
EBIT Growth (%) arrow
-85.46 136.39 18.70 -3.99 93.17
Net Profit Growth (%) arrow
-106.10 378.76 17.50 42.89 -115.58
EPS Growth (%) arrow
-108.86 353.27 26.84 50.42 -73.87
Book Value Growth (%) arrow
32.01 816.12 164.02 -0.70 -13.57

Valuation Ratios

 PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Price / Earnings arrow
8.98 -59.76 36.06 15.79 -2,869.63
Price / Book Value arrow
-29.85 -80.42 35.44 5.72 10.04
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
7.76 -121.54 28.08 12.44 25.04
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Debt to Equity arrow
-3.24 0.00 0.00 0.00 1.77
Short term debt to equity ratio arrow
-0.44 0.05 0.00 0.00 0.09
Current Ratio arrow
3.39 2.99 0.73 3.46 5.90
Quick Ratio arrow
3.28 2.32 0.73 3.38 5.90
Interest Coverage arrow
0.64 1.62 -- -- -1.72

Operating Efficiency Ratios

 PTC Therapeutics (PTCT) Ascendis Pharma A/S - ADR Medpace Holdings (MEDP) Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%) arrow
23.70 21.25 15.88 13.74 1.28
Asset Turnover arrow
0.28 0.37 0.89 0.83 0.34
Receivable days arrow
35.90 85.52 50.42 43.48 1.50
Inventory Days arrow
261.74 1,056.70 -- 96.17 --
Payable days arrow
159.73 331.01 6.26 147.97 221.81
Cash Conversion Cycle arrow
137.90 811.21 -- -8.32 --
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...